A modern view of the etiology, epidemiology and clinical manifestations of Behcet’s disease
pdf (Українська)

Keywords

Behcet’s disease, clinical manifestations, diagnosis, pathogenesis, mouth ulcers, genital ulcers, eye damage

How to Cite

Golovach, I., & Yehudina, Y. (2020). A modern view of the etiology, epidemiology and clinical manifestations of Behcet’s disease. The Practitioner, (1), 34-44. Retrieved from https://plr.com.ua/index.php/journal/article/view/509

Abstract

Behcet’s disease (BD) is a systemic vasculitis of unknown etiology, which is characterized by of variable vessel involvement, and the main clinical manifestations are recurrent oral aphthous ulcers and genital sores, ocular, joints, gastrointestinal tract and central nervous system lesions. Although BD is increasingly being diagnosed and effectively treated, the etiology of this disease remains unclear. In addition, there is a difficulty in developing universal classification criteria, which is associated with geographical differences in the prevalence, severity of certain clinical signs and the disease severity. This literature review provides the latest data on the epidemiology, etiopathogenesis, and clinical manifestations of BD. Both certain or «strong» signs for the diagnosis of BD, as well as probable or «weak» are presented. «Strong» criteria are features that define the BD as a separate nosological unit, that is, a pathological condition with a unique pathogenesis and more or less unique features that distinguish it from other pathological conditions. On the contrary, «weak» symptoms are those elements that indicate more than one common pathogenetic mechanism with another disease. Diagnosis of BD is even more complicated by the absence of specific histopathological or laboratory components that can be used in diagnosis. Further research and clinical work are needed with an emphasis on understanding phenotypic expression and the geographical impact on BD development.

pdf (Українська)

References

1. Лисицына Т.А., Алекберова З.С., Голоева Р.Г., Давыдова Г.А. Болезнь Бехчета: клинические проявления, современные принципы диагностики и терапии // Научно-практическая ревматология. — 2019. — T. 57. — C. 553-563.
2. Tan S.Y., Poole P.S. Hulusi Behçet (1889-1948): Passion for dermatology // Singapore Med J. — 2016. — Vol. 57, 7. — P. 408-409.
3. International Team for the Revision of the International Criteria for Behcet’s Disease (ITR-ICBD). The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria // J. Eur. Acad. Dermatol. Venereol. — 2014. — Vol. 28. — P. 338-47.
4. Skef W. Gastrointestinal Behçet’s disease: a review // World J. Gastroenterol. — 2015. — Vol. 21. — P. 3801-12.
5. Yazici H., Ugurlu S., Seyahi E. Behçet syndrome: is it one condition? // Clin. Rev. Allergy Immunol. — 2012. — Vol. 43. — P. 275-280.
6. Tugal-Tutkun I., Onal S., Ozyazgan Y., et al. Validity and agreement of uveitis experts in interpretation of ocular photographs for diagnosis of Behçet uveitis // Ocul. Immunol. Inflamm. — 2013. — Vol. 22. — P. 461-468.
7. Mat M.C., Goksugur N., Engin B., et al. The frequency of scarring after genital ulcers in Behçet’s syndrome: a prospective study // Int. J. Dermatol. — 2006. — Vol. 45. — P. 554-556.
8. Yazici Y., Yazici H. Behcet’s Syndrome // Springer New York. Dordrecht Heidelberg London; 2010. ISBN978-1-4419-5640-8.
9. Tascilar K., Melikoglu M., Ugurlu S., et al. Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course //
Rheumatology. — 2014. — Vol. 53. — P. 2018-2022.
10. Yazici H., Seyahi E., Hatemi G., et al. Behçet syndrome: a contemporary view // Nat. Rev. Rheumatol. — 2018. — Vol. 14. — P. 107-119.
11. Valenti S., Gallizzi R., De Vivo D., Romano C. Intestinal Behçet and Crohn’s disease: two sides of the same coin // Pediatr. Rheumatol. — 2017. — Vol. 15. — P. 33.
12. Hatemi I., Hatemi G., Celik A.F., et al. Frequency of pathergy phenomenon and other features of Behçet’s syndrome among patients with inflammatory bowel disease // Clin. Exp. Rheumatol. — 2008. — Vol. 26. — P. 91-95.
13. Takeuchi M., Mizuki N., Meguro A., et al. Dense genotyping of immunerelated loci implicates host responses to microbial exposure in Behçet’s disease susceptibility // Nat. Genet. — 2017. — Vol. 49, 3. — P. 438-443.
14. McGonagle D., Aydin S.Z., Gül A., et al. ‘MHC — I — opathy’ — unified concept for spondyloarthritis and Behçet disease // Nat. Rev. Rheumatol. — 2015. — Vol. 11. — P. 731-740.
15. Schett G., Lories R.J., D’Agostino M.A., et al. Enthesitis: from pathophysiology to treatment // Nat. Rev. Rheumatol. — 2017. — Vol. 13. — P. 731-741.

Downloads

Download data is not yet available.